Alternative splicing in ovarian cancer
Abstract Ovarian cancer is the second leading cause of gynecologic cancer death worldwide, with only 20% of cases detected early due to its elusive nature, limiting successful treatment. Most deaths occur from the disease progressing to advanced stages. Despite advances in chemo- and immunotherapy,...
Saved in:
| Main Authors: | Liwei Wei, Yisheng Li, Jiawang Chen, Yuanmei Wang, Jianmin Wu, Huanming Yang, Yi Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-10-01
|
| Series: | Cell Communication and Signaling |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12964-024-01880-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alternative Splicing: Emerging Roles in Anti-Aging Strategies
by: Lingyue Gao, et al.
Published: (2025-01-01) -
Dysregulation and Therapeutic Targeting of RNA Splicing Variants in Cancer
by: Doaa Rabaya, et al.
Published: (2024-09-01) -
Splicing to orchestrate cell fate
by: Xurui Zhang, et al.
Published: (2025-03-01) -
Alternative splicing in stem cells and development: research progress and emerging technologies
by: Yan Jin, et al.
Published: (2025-06-01) -
The nexus of long noncoding RNAs, splicing factors, alternative splicing and their modulations
by: Pushkar Malakar, et al.
Published: (2024-12-01)